Sign in

International Consortium on Meningiomas (ICOM)

@icomeningioma.bsky.social
83 followers 28 following 269 posts

ICOM, under the leadership of Dr. Gelareh Zadeh, increases awareness and conducts high quality cutting-edge research on meningiomas.

PostsRepliesMedia
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 09/10/2026
This recent trial looked to assess whether #AdjuvantRadiotherapy reduces recurrence of WHO grade 2 atypical #meningiomas compared with observation in patients with a newly diagnosed atypical meningioma who have undergone complete surgical resection. bit.ly/4ydEPOQ
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 07/10/2026
The CBTC convened a meningioma pathology board of both veterinarian pathologists and physician neuropathologists, and conducted a comprehensive review of 190 cases of #canine #meningioma to review similarities and differences to human meningioma. bit.ly/4djnADq
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 05/10/2026
This new research indicates that some #atypical #histopathologic features are more powerful than others, and can be used on initial screening to increase the yield of molecular profiling of #meningiomas. bit.ly/4j3VZtB
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 02/10/2026
This article in Neurosurgical Focus provides clinical perspectives for the practicing #neurosurgeon on integrative multiomic analyses of aggressive #meningiomas. Read here: bit.ly/4yAAepR
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 30/09/2026
Read the article “Anatomical location reflects distinct #cytogenetic signatures in #intracranial #meningiomas” in this month’s edition of Neurosurgical Focus: bit.ly/4xRVUh0
001
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 28/09/2026
The ROAM/EORTC-1308 trial is a landmark international randomised phase III trial, with the presentation recognized with the EANO Best Oral Presentation Award for Clinical Research, awarded to Jenkinson at the 2026 meeting. Read about the study here: bit.ly/4ydEPOQ
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 21/09/2026
In this newly published article, Brooke C. Braman MD and David R. Raleigh MD, PhD examine integrating #MolecularClassification into postoperative #intracranial #meningioma management. Read now: bit.ly/4cJ8mY8
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 18/09/2026
‘Clinical perspectives for the practicing #neurosurgeon on integrative #multiomic analyses of aggressive #meningiomas’ is now available in the September #meningioma issue of #NeurosurgicalFocus bit.ly/4hp9vGP
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 16/09/2026
This new research found that #Meningiomas exhibit a significant association between their #anatomical origin and #chromosomal #alterations. Read the full article here: bit.ly/4xRVUh0
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 14/09/2026
The topic of the September issue of #NeurosurgicalFocus is around #Meningiomas: Emerging Insights and Management Implications, with Wenya Linda Bi, Stephen Magill, Jennifer Moliterno, @FarshadNassiri, Soichi Oya, and Michel Kalamarides as editors. bit.ly/4r9WXGx
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 09/09/2026
The full text of ‘Pre-operative #embolization of #SkullBase #meningiomas’ by Omar Ashraf, Stacey Q Wolfe, Samuel Emerson, Brock Yager, Wenya Linda Bi, and Omaditya Khanna is now available in #NeuroOncology Advances: academic.oup.com/noa/article/...
academic.oup.com
Pre-operative embolization of skull base meningiomas
Abstract. Skull base meningiomas are challenging tumors to resect and confer a high risk of surgical morbidity due to their location in deep-seated regions
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 07/09/2026
The #MeningiomaSymposium 2026 taking place in Rome is just three weeks away. Learn more about this focused, single-track meeting that will bring together international leaders in #meningioma #research and #ClinicalCare here: meningiomasymposium.wma.co.at#programme
011
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 07/09/2026
In this study, the authors produced a #DeepLearning model that addresses an unmet need for automated #volumetric measurements of #meningiomas and created a reliable metric for quantifying meningioma burden. Read the full article here: academic.oup.com/noa/article/...
academic.oup.com
A deep learning algorithm for fully automated volumetric measurement of meningioma burden
AbstractBackground. We sought to develop a deep learning (DL) model to enable fully automated 3D segmentation and volumetric assessment of meningioma burde
010
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 04/09/2026
In this study, the authors produced a #DeepLearning model that addresses an unmet need for automated #volumetric measurements of #meningiomas and created a reliable metric for quantifying meningioma burden. Read the full article here: bit.ly/4qsK76c
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 02/09/2026
Read ‘How #AI is transforming medicine’ from #MayoClinic, or watch the episode of ‘Tomorrow’s Cure,’ where @gelarehzadeh.bsky.social discusses the new possibilities afforded by AI: mcpress.mayoclinic.org/research-inn...
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 31/08/2026
To overcome the challenge of obtaining & preserving tissue for molecular diagnostics, authors tested NICO APS’ capabilities vs traditional protocols in 20 #meningioma resections, focusing on circRNA profiles as potential #ClinicalBiomarkers. bit.ly/4wUSeLd
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 28/08/2026
‘A fluorescein-conjugated somatostatin receptor antagonist adapter for chimeric antigen receptor T cell therapy of #meningioma’ is now available in #NeuroOncology Advances: bit.ly/45f8ieB
010
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 26/08/2026
Investigations into #MolecularProfiling have established genomic architecture of #meningioma, but distribution of copy number alterations & short somatic variants across demographic groups is incompletely understood. This study defines a benchmark for this bit.ly/4zsvHal
011
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 24/08/2026
Read ‘Modern molecular profiling recontextualizes the NRG/RTOG 0539 trial and reveals hidden high-risk and #radiotherapy-resistant #meningiomas’ in #NeuroOncology here: pubmed.ncbi.nlm.nih.gov/42143623/
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 21/08/2026
The #MeningiomaSymposium is coming up on September 28, and includes several of our #ICOM members as speakers, including: Arie Perry W. Linda Bi Felix Sahm Jennifer Moliterno David R. Raleigh Christian Mawrin Learn more about their topics and the event: bit.ly/4zkMV9f
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 19/08/2026
Recent #ICOM publications highlight advances across #meningioma care, from improved tissue preservation for molecular assays to single‑cell mapping of tumor ecosystems, to CAR‑T targeting strategies. Here are some July August papers.
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 17/08/2026
The full article of ‘A #DeepLearning algorithm for fully automated volumetric measurement of #meningioma burden’ is now available in #NeuroOncology Advances: bit.ly/4qsK76c
012
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 12/08/2026
‘#NICO Myriad Automated Preservation System improves #meningioma sample quality for #MolecularPathology assays’ is now available in the Journal of Neuropathology & Experimental Neurology. Read the full article here: bit.ly/4wUSeLd
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 10/08/2026
Key points of this new study: 1️⃣ #Octofluo is a SSTR2-targeted, FITC-linked bispecific CAR-T cell engager. 2️⃣ Octofluo plus FITC-targeted CAR-T cells are active against SSTR2+ #meningioma and induce a host anti-tumor immune response. academic.oup.com/noa/article/...
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 05/08/2026
‘Distinct molecular subgroups in #pediatric and young-onset #meningiomas require age-adapted risk stratification’ is now out in #NatureCommunications - read it here: go.nature.com/3RIMOn5
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 31/07/2026
-Modern molecular profiling redefines risk, reveals high-risk RTOG-0539 cohort #meningiomas -Proliferative tumors show radiotherapy resistance linked to genomic instability -Molecular classification outperforms WHO grade in predicting radiotherapy response pmc.ncbi.nlm.nih.gov/articles/PMC...
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 29/07/2026
This exploratory analysis in #IJROBP found no evidence that #RadiationTherapy alone results in significant changes in peripheral lymphocyte counts in patients with primary #BrainTumors treated to limited intracranial volumes. bit.ly/4fysJaP
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 27/07/2026
Read the recent research letter around observed unanticipated postoperative improvements in #glycemic control among patients with #OlfactoryGroove #meningiomas and #diabetes, examining the magnitude and durability of this outcome: bit.ly/3TbYFdV
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 25/07/2026
Read about the recent study comparing the prognostic performance of #SimpsonGrade vs #MRI-based extent of resection paradigms for predicting recurrence and survival across #meningioma histomolecular subgroups: journals.lww.com/neurosurgery...
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 20/07/2026
Read the new article in #NatureCommunications showing that #pediatric and #YoungAdult #meningiomas form a distinct molecular entity and support age‑adapted risk refinement that integrates molecular features with key clinical determinants: go.nature.com/3RIMOn5
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 15/07/2026
In case you missed it, ‘#DeepLearning for H&E-based #meningioma molecular classification and outcome prediction: a retrospective cohort study’ is now out: bit.ly/4ft190x
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 13/07/2026
Studies have linked #progestin exposure to increased #meningioma risk. The molecular basis of meningiomas associated with common injectable contraceptive #DMPA remains undefined. This article analyzes meningiomas from women with long-term DMPA exposure. bit.ly/3QP6UM5
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 10/07/2026
The STELLAR-201 #ClinicalTrial is now enrolling. This is an Exelixis Phase 2, single-arm, open-label study evaluating zanzalitinib for patients with recurrent or progressive #meningioma with histologically confirmed WHO grade 1, 2 or 3. bit.ly/4fs564Y search NCT07428616
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 08/07/2026
This recent article in #NeuroOncology found that exposure to #MedroxyprogesteroneAcetate increases the risk of #meningioma by 1.5- to 5.5-fold, and the risk of craniotomy for tumor resection is elevated after DMPA exposure. Read more: academic.oup.com/neuro-oncolo...
011
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 06/07/2026
Our #ICOM members are engaged in leading-edge research into #meningiomas, with several new articles coming out every month. Here are some highlights from May and June!
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 03/07/2026
Read about a recent long-term analysis of NRG Oncology RTOG 0539 phase II trial of observation for low-risk #meningioma and #radiotherapy for intermediate- and high-risk meningioma: bit.ly/4oGuiYo
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 01/07/2026
Learn more about @gelarehzadeh.bsky.social’s path to #neurosurgery and an overview of #BIONIC, a multidisciplinary ecosystem aimed at restoring #brain function, in the new @mayocliniccancer.bsky.social article and video: mayocl.in/3Stf4Kw
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 29/06/2026
Register now for the #Meningioma #Symposium 2026, an international, single-track scientific meeting on meningioma biology and care. 📍 Rome, Italy 📆 28 September 2026 For more information and the full programme, click here: meningiomasymposium.wma.co.at
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 25/06/2026
Read this study which systematically investigates the radiosensitising potential of #dacinostat, a pan-histone deacetylase inhibitor, for aggressive #meningioma and demonstrates its superior synergy with radiation compared to other FDA-approved HDACis: go.nature.com/4oDNohQ
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 24/06/2026
‘Spatially resolved single-cell analyses of human #meningioma identify novel cell states influencing tumor microenvironment and progression’ is now out in #NatureGenetics. Read the full article here: go.nature.com/3POUPWQ
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 22/06/2026
This article reviews the indications and outcomes from pre-operative #embolization of #SkullBase #meningiomas, discusses the embolic materials available for use and their risks and benefits, and relevant vascular anatomy as it pertains to blood supply. bit.ly/4d3voID
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 19/06/2026
In case you missed it: The latest edition of the #ICOM newsletter is now available! It contains information on Dr. S.L.N. Maas’ #AI article summarizer tool, events, and new #meningioma articles from our members. Read it here: adobe.ly/4ufL81O
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 17/06/2026
Have you registered yet for the 100th Anniversary Meeting of #SBNS? We will be hosting two joint #ICOM-#BIMS #meningioma sessions, and hope to see you there! Find out more about #SBNS100 here: bit.ly/421mpCv
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 15/06/2026
This new study produced a #DeepLearning model that addresses an unmet need for automated volumetric measurements of #meningiomas and created a reliable metric for quantifying meningioma burden. Read more about this model in #NeuroOncology Advances: bit.ly/4tWFgKn
020
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 12/06/2026
In case you missed it: ‘Loss of #meningothelial identity and mesenchymal fate switching in NF2-mutant #meningiomas’ is now available in Acta Neuropathologica: bit.ly/4wfXybX
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 09/06/2026
‘Spatially resolved single-cell analyses of human #meningioma identify novel cell states influencing tumor microenvironment and progression’ is now out in #NatureGenetics Read the full article here: www.nature.com/articles/s41... @gelarehzadeh.bsky.social
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 08/06/2026
Read the new study in @LancetDigitalH evaluating #AI #DeepLearning for characterizing molecular subtypes, predicting risk of recurrence, and identifying chromosome copy number alterations in H&E-stained #meningioma tissue samples bit.ly/4ft190x @ap_landry @gelarehzadeh
030
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 05/06/2026
Read this recent study which aimed to define the molecular trajectory of sarcomatous transformation in #meningiomas and to clarify whether these tumors represent a biological endpoint distinct from conventional anaplastic meningiomas: bit.ly/4wfXybX
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 03/06/2026
The Q2 edition of the #ICOM newsletter is now out! In it you’ll find: - An #AI article summarizer tool by Dr. S.L.N. Maas - information about ICOM sessions at #SBNS100 - The latest #Meningioma articles from our members adobe.ly/4ufL81O
000
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 01/06/2026
Read about the recent phase 1 trial evaluating the safety and efficacy of dose escalation with intensity-modulated #ProtonTherapy for grade 2 and 3 #meningiomas: bit.ly/42OjCNp @FelixEhretMD
000